pmc.ncbi.nlm.nih.gov
pmc.ncbi.nlm.nih.gov
https://pmc.ncbi.nlm.nih.gov › articles › PMC8496765
Association between Epstein‐Barr‐Virus reactivation and development of ...
To the Editor, Post‐viral fatigue after SARS‐CoV‐2 infection is a major concern in the ongoing COVID‐19 pandemic. Up to 10% of patients develop Long‐COVID, 1 a syndrome defined by the National Institute for Health and Care Excellence as post‐infectious long‐term symptoms for more than 12 weeks, which cannot be explained by alternative pathologies. 1 While some Long‐COVID ...
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May ...
Patients with post-COVID symptoms showed a reactivation of EBV in 42.6%, HHV-6 in 25.0%, and reactivation of both EBV and HHV-6 in 32.4%. The 68 patients who were positive for reactivation were more likely to need more intensive care and have a longer median stay in the hospital, 16 days as opposed to 7 days for controls, which was ...
Association between Epstein-Barr-Virus reactivation and ... - PubMed
Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue. Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue Allergy. 2023 Jan;78(1):297-299. doi: 10.1111/all.15471. Epub 2022 Aug 23. Authors Johanna Rohrhofer 1 ...